Lars Toleikis
- Molecular Biology
- Radiology, Nuclear Medicine and Imaging top 2%
- Oncology top 10%
- Immunology
- Biotechnology top 5%
- Co-authors
- Harald KolmarStefan BeckerSimon KrahBjörn HockStefan ZielonkaStefan DübelAndré FrenzelLaura Rhiel
- Topics
- Monoclonal and Polyclonal Antibodies Research (31 papers)Glycosylation and Glycoproteins Research (10 papers)Protein purification and stability (9 papers)
- Partner nations
- GermanyUnited StatesAustria
In The Last Decade
Lars Toleikis
33 papers receiving 919 citations
Peers
Comparison fields: 5 of 56
- Molecular Biology 645
- Radiology, Nuclear Medicine and Imaging 638
- Oncology 245
- Immunology 216
- Biotechnology 102
Countries citing papers authored by Lars Toleikis
This map shows the geographic impact of Lars Toleikis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lars Toleikis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lars Toleikis more than expected).
Fields of papers citing papers by Lars Toleikis
This network shows the impact of papers produced by Lars Toleikis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lars Toleikis. The network helps show where Lars Toleikis may publish in the future.
Co-authorship network of co-authors of Lars Toleikis
This figure shows the co-authorship network connecting the top 25 collaborators of Lars Toleikis. A scholar is included among the top collaborators of Lars Toleikis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lars Toleikis. Lars Toleikis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 5 | |
| 3 | 4 | |
| 4 | 0 | |
| 5 | 1 | |
| 6 | 2 | |
| 7 | 16 | |
| 8 | 21 | |
| 9 | 4 | |
| 10 | 22 | |
| 11 | 47 | |
| 12 | 35 | |
| 13 | 32 | |
| 14 | 73 | |
| 15 | 100 | |
| 16 | 15 | |
| 17 | 123 | |
| 18 | 64 | |
| 19 | 28 | |
| 20 | 10 |
About Lars Toleikis
Lars Toleikis is a scholar working on Radiology, Nuclear Medicine and Imaging, Immunology and Biotechnology, having authored 34 papers that have together received 941 indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (31 papers), Glycosylation and Glycoproteins Research (10 papers) and Protein purification and stability (9 papers). The work is most often cited by research in Radiology, Nuclear Medicine and Imaging (638 citations), Biotechnology (102 citations) and Immunology (216 citations). Lars Toleikis has collaborated with scholars based in Germany, United States and Austria. Frequent co-authors include Harald Kolmar, Stefan Becker, Simon Krah, Björn Hock, Stefan Zielonka, Stefan Dübel, André Frenzel, Laura Rhiel, Carolin Sellmann and Lukas Pekar. Their work appears in journals such as Journal of Biological Chemistry, The Journal of Immunology and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.